In previous studies, we found that deflamin had anti-MMP-2 and -MMP-9 activities in CRC cell line HT-29, as well as anti-inflammatory role in mouse models of induced-intestinal colitis [21]. The gene discussed is MMP9; the disease is colorectal carcinoma.